DE2702530A1 - Verfahren zur herstellung von 3,4-dihydro-2(1h)-chinazolinon-derivaten - Google Patents

Verfahren zur herstellung von 3,4-dihydro-2(1h)-chinazolinon-derivaten

Info

Publication number
DE2702530A1
DE2702530A1 DE19772702530 DE2702530A DE2702530A1 DE 2702530 A1 DE2702530 A1 DE 2702530A1 DE 19772702530 DE19772702530 DE 19772702530 DE 2702530 A DE2702530 A DE 2702530A DE 2702530 A1 DE2702530 A1 DE 2702530A1
Authority
DE
Germany
Prior art keywords
general formula
dihydro
carried out
zinc
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772702530
Other languages
German (de)
English (en)
Inventor
Shigenari Katayama
Masao Koshiba
Hisao Yamamoto
Michihiro Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of DE2702530A1 publication Critical patent/DE2702530A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C07D239/82—Oxygen atoms with an aryl radical attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE19772702530 1976-01-23 1977-01-21 Verfahren zur herstellung von 3,4-dihydro-2(1h)-chinazolinon-derivaten Withdrawn DE2702530A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP692076A JPS5291885A (en) 1976-01-23 1976-01-23 3,4-dihydro-2(1h)-quinazolinone derivatives

Publications (1)

Publication Number Publication Date
DE2702530A1 true DE2702530A1 (de) 1977-07-28

Family

ID=11651662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772702530 Withdrawn DE2702530A1 (de) 1976-01-23 1977-01-21 Verfahren zur herstellung von 3,4-dihydro-2(1h)-chinazolinon-derivaten

Country Status (13)

Country Link
US (1) US4048168A (en:Method)
JP (1) JPS5291885A (en:Method)
AT (1) AT353276B (en:Method)
CA (1) CA1069505A (en:Method)
CH (1) CH625231A5 (en:Method)
DE (1) DE2702530A1 (en:Method)
DK (1) DK141064B (en:Method)
FR (1) FR2338934A1 (en:Method)
GB (1) GB1525892A (en:Method)
HU (1) HU174389B (en:Method)
MX (1) MX3959E (en:Method)
NL (1) NL7614574A (en:Method)
SE (1) SE422324B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5271483A (en) * 1975-12-11 1977-06-14 Sumitomo Chem Co Ltd Synthesis of 2(1h)-quinazolinone derivatives
US4282226A (en) * 1978-04-26 1981-08-04 E. R. Squibb & Sons, Inc. Thioxopyrazolo[1,5-c]quinazoline derivatives, anti-allergic compositions and methods for treating allergic conditions by parenteral administration, aerosol or insufflation
EP1394242A3 (en) * 2002-08-07 2004-04-21 Rohm And Haas Company Cyclic thioureas and their use as additives for lubricating oils
DK1589973T4 (da) * 2003-01-23 2013-04-08 Shire Biopharmaceuticals Holdings Ireland Ltd Formulering og fremgangsmåder til behandling af thrombocytæmi
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
US7910597B2 (en) * 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3748331A (en) * 1971-05-06 1973-07-24 Sandoz Ag 1,4-disubstituted-methylenedioxy -2-(1h)-quinazolinones and quinazolinthiones

Also Published As

Publication number Publication date
DK141064C (en:Method) 1980-06-23
AT353276B (de) 1979-11-12
SE7700533L (sv) 1977-07-24
CA1069505A (en) 1980-01-08
SE422324B (sv) 1982-03-01
CH625231A5 (en:Method) 1981-09-15
MX3959E (es) 1981-10-15
FR2338934A1 (fr) 1977-08-19
JPS5291885A (en) 1977-08-02
NL7614574A (nl) 1977-07-26
US4048168A (en) 1977-09-13
DK141064B (da) 1980-01-07
DK22277A (en:Method) 1977-07-24
GB1525892A (en) 1978-09-20
ATA22777A (de) 1979-04-15
HU174389B (hu) 1979-12-28
AU2131477A (en) 1978-02-23
FR2338934B1 (en:Method) 1980-12-19

Similar Documents

Publication Publication Date Title
DE3875848T2 (de) Herstellung von 2-(2-pyridylmethylsulfinyl)-benzimidazol-verbindungen.
EP0010063B1 (de) Verfahren zur Herstellung von Furanyl-benzazolen
DE2647853A1 (de) Verfahren zur herstellung von 3,4- dihydro-2-(1h)-chinazolinonen und 3,4-dihydro- 2(1h)-chinazolinthionen
DE2702530A1 (de) Verfahren zur herstellung von 3,4-dihydro-2(1h)-chinazolinon-derivaten
DE2519480A1 (de) Aryl-oxo-heptensaeuren
DE2165056B2 (de) Verfahren zur Herstellung von Chinazolinonen
DE2707102C2 (de) Verfahren zur regiospezifischen Herstellung von o-Aminophenylketonen
DE2740331C3 (de) 2-(-4-Cyano-piperanzino)-4-amino-6,7-dimethoxy-chinazolin und dessen Verwendung zur Herstellung von 2-[4-(2-Furoyl)piperazin-o]-4-amino-6,7-dimethoxychinazolin
DE2118315C3 (de) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2259222A1 (de) Neue, 1,1-dioxothiazolidin-4-one und verfahren zu deren herstellung
DE2841644C2 (en:Method)
DE2320040A1 (de) Verfahren zur herstellung von 7acylamino-desacetoxy-cephalosporansaeureester
EP0107622A1 (de) Neue Benzodioxolderivate, Verfahren zu deren Herstellung und entsprechende pharmazeutische Zusammensetzungen
EP0653423B1 (de) Verfahren zur Herstellung von substituierten Chinazolin-2,4-dionen
DE1795500A1 (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
DE1812231B2 (de) Verfahren zur herstellung von 3alkyl-5-phenyl-1,3-dihydro-2h-1,4benzodiazepin-2-onderivaten
DE2435378A1 (de) Verfahren zur herstellung von aryloxyalkyldiketonen und -ketoestern
DE2337285A1 (de) Chinazolinonverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2233520A1 (de) Verfahren zur herstellung von penicillinund penicillinsulfoxidestern
DE69711397T2 (de) Herstellung von einem hydrazon-beta-ketoester durch reaktion mit einem diazoester
DE2406972A1 (de) Verfahren zur herstellung von 5-sulfa- moylanthranilsaeuren
DE2439454A1 (de) Verfahren zur herstellung von chinazolinon-derivaten
DE1770711A1 (de) 7-Triazolyl-cumarine
CH625512A5 (en:Method)
DE2747121A1 (de) 6-(m-aminophenyl-2,3,5,6-tetrahydroimidazo eckige klammer auf 2,1-b eckige klammer zu thiazolderivate, verfahren zu ihrer herstellung und ihre verwendung

Legal Events

Date Code Title Description
8141 Disposal/no request for examination